The first piece of evidence of a link between mutations in NOD2 and CD [an inflammatory bowel disease (IBD)] was provided by Hugot et al. which identified three single nucleotide polymorphisms (SNPs) in the IBD1 locus associated with increased risk for CD (77). Here, NOD2 is linked to inflammatory bowel disease.